Vaccines

Targeting the Greatest Threats in Infectious Disease

Our global vaccine business is applying innovation to address some of the world’s most challenging infectious diseases. By leveraging global, regional and local partnerships, we help to prevent illness and prepare for future threats, as well as support and increase access to medicine.

Vaccines represent a new dimension of global impact for Takeda. We are reaching more people and saving more lives than ever before, and this is an extraordinary privilege, responsibility and opportunity for all of us. Together, we are building on Takeda’s long history and developing a strong pipeline for the future.

Our Mission

To develop and deliver innovative vaccines that tackle the toughest problems in public health and improve the lives of people around the world.

Our Vision

To protect the health of people everywhere through vaccines that address the most important infectious diseases.

Culture

In our day-to-day work, all over the world, we focus on the following values while upholding the highest ethical standards:

  • Integrity
  • Perseverance
  • Fairness
  • Honesty

Our Vaccines

  • BLB-750 (H5N1 Flu)
  • Measles Rubella
  • Mumps
  • Diphtheria Tetanus Toxoid
  • Seasonal Flu (Denka & Kaketsuken)
  • Varicella (Biken)
  • Japanese Encephalitis (Biken)

Our Leadership

Vaccines represent a new dimension of global impact - successful leadership at Takeda can be encompassed in these four pillars:

DEMONSTRATINGstrategic enterprise thinking, finding innovative ways to serve patients and build trust, reputation and business

CREATINGthe environment that inspires and enables people to move the organization forward

FOCUSINGon the few priorities and delivers superior results

ELEVATINGthe capabilities of the organization for now and the future

战略重点

There are two priorities for VBU employees: developing new vaccines to meet unmet health needs and making sure they’re available and accessible to people who need them most.

Our Vaccine Pipeline

We have developed a pipeline that focuses on diseases that impact disproportionally low- and middle-income countries. Currently, our vaccine research is focused on dengue, zika and norovirus.

Preclinical

  • Chikungunya Vaccine
    (TAK-503)

PHASE 1

  • ZIKA VACCINE
    (TAK-426)
  • ENTEROVIRUS VACCINE
    (TAK-021)

phase 2

  • Norovirus Vaccine
    (TAK-214)

phase 3

  • Dengue Vaccine
    (TAK-003)

查看所有疫苗的工作

Search

Key Locations

  • Cambridge, MA (HQ) | Global VBU HQ Operations
  • Zurich (HQ)
  • Singapore
  • Osaka/Tokyo (HQ)
  • São Paulo
  • Singen
  • Hikari

Job Alerts

Would you like to receive relevant opportunities in your inbox as soon as they’re posted?

SIGN UP

Sign up for Job Alerts

Sign up to receive the latest career opportunities directly to your inbox.

Interested In Select a job category from the list of options. Select a location from the list of options. Finally, click “Add” to create your job alert.

Are you interested in remote roles? Select One

By submitting your information, you acknowledge that you have read ourprivacy policyand consent to receive email communication from Takeda Pharmaceuticals.

Talent Network

Are you interested in company news, attending career events, and hearing more from Takeda?

Join

By submitting your information, you acknowledge that you have read ourprivacy policyand consent to receive email communication from Takeda Pharmaceuticals.